Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > Six Sigma – Business Realities

Tags

  • packaged
  • reasons
  • combination
  • biological product
  • companies involved

  • Links

  • Fears that Drive Reactions: The Wholistic Perception
  • Why You Should Never Feed A Snake Live Food
  • Saddam, America's Good Son
  • Digg It - Six Sigma – Business Realities

    There are criticisms about Six Sigma which say that the methodology is an elitist technique. Through all this, Six Sigma has proven itself to be a highly
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    effective management tool. Most of the incidences of roadblocks to Six Sigma have come from external sources. In the rare events of its failures, they a
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e ultimately determined to have been caused by improper training of belts or Master Black Belts, not because of system errors.

    How the Business World Lo
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    oks at Six Sigma

    Six Sigma is looked upon as a strategic business tool in the business circles, notwithstanding what others would like to think. However
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    it is regarded as the ultimate tool of improvement and profitability, able to both meet and exceed customer expectations and increase customer satisfact
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    on levels.

    Factors That Determine Six Sigma’s Success

    Typically Six Sigma’s success depends a lot on two things. They are the steadfast commitment by t
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    op management to implementation and the success of the black belts as implementers.

    The commitment of the top management is necessary until the completi
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    n of the program. The reasons cited for the lack of interest by management are basically financially oriented. Hefty consultation fees in millions of dol
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    lars that run for years and the training cost for the belts are the main reason - because Six Sigma takes time to implement, to show results and impact r
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    turn on investment, the expenses incurred in Six Sigma implementation bears heavily on the bottom line of the company.

    In addition to these reasons, the
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    e are roadblocks hit by black belts. These require intervention by Champions to diffuse tensions and resolve problems in implementation. These problems c
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    an be in the form of non-cooperation from a specific business division. Competition between divisions in the company can cause a few sparks to fly. In ca
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    es like these, upper management needs to take quick and decisive action to diffuse the tensions. If this fails, it can result in lack of motivation of
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    the team.

    The question on whether or not the belts succeed depends a lot on the training and their experiences. But unfortunately there is a big gap her
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    as there is no centralized training or and no standardization. Universities, private institutes and corporations train Six Sigma candidates. Due to this
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    it is observed that there is a big question mark over the quality of training. Belts from different training backgrounds can fail to make a solid team,
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    as there are chinks in Six Sigma training uniformity due to disparities in training levels.

    Summarized View

    You can summarize the business realities fa
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ed by Six Sigma as follows: 1. Huge cost and time required for implementation

    2. Slow showing of financial benefits and customer satisfaction

    3. Possi
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    bility of management losing interest midway

    4. High cost of consultants

    5. Skirmishes between the belts and the rest of the staff threatening team cohe
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    iveness

    6. Elitist notion of 6 sigma professionals; income disparities with the staff demotivate the latter

    7. Financial benefit: 0.5% to 1% per projec


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/22856/diggit-Six-Sigma--Business-Realities.html">Six Sigma – Business Realities</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/22856/diggit-Six-Sigma--Business-Realities.html]Six Sigma – Business Realities[/url]

    Related Articles:

    21 Proven Ways To Use PR to Build Your Brand (Part Three)

    Going Back To School

    Advantages of a Franchise Business

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com